Unlike hematopoietic cancers where PTPN13 negative transcriptional regulation has an anti-tumor effect by sensitizing cells to FAS-induced apoptosis, PTPN13 negative transcriptional regulation in solid cancers has a pro-tumor effect through activation of proliferation pathways (Table 3). This evidence concerns the gene FAS and hematopoietic and lymphoid cell neoplasm.